| Revenues | 601.11M |
| Cost of sales | -355.15M |
| Gross profit | 245.96M |
| Selling, general and administrative expenses | -126.66M |
| Research and development | -33.51M |
| Amortization of intangibles | -23.8M |
| Income from equity method investment | |
| Operating income | 61.98M |
| Interest expense | |
| Interest income | |
| Other income | |
| Income (loss) from continuing operations before taxes | 38.47M |
| Income tax benefit (expense) | -2.9M |
| Income (loss) from continuing operations | |
| Loss from discontinued operations, net of tax | |
| Net income (loss) | 35.65M |
| Basic | 42.13M |
| Diluted | 42.6M |
| Continuing operations | 0.69 |
| Discontinued operations | 0 |
| Net income | 0.69 |
| Continuing operations | 0.68 |
| Discontinued operations | 0 |
| Net income | 0.68 |
| Dividends declared per share | 0.05 |